SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Statistics

Total Valuation

SCI Pharmtech has a market cap or net worth of TWD 5.80 billion. The enterprise value is 6.68 billion.

Market Cap	5.80B
Enterprise Value	6.68B

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	Jul 1, 2025

Share Statistics

SCI Pharmtech has 119.51 million shares outstanding. The number of shares has increased by 0.89% in one year.

Current Share Class	119.51M
Shares Outstanding	119.51M
Shares Change (YoY)	+0.89%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	5.40%
Owned by Institutions (%)	0.63%
Float	67.84M

Valuation Ratios

The trailing PE ratio is 50.50.

PE Ratio	50.50
Forward PE	n/a
PS Ratio	4.17
PB Ratio	1.08
P/TBV Ratio	1.09
P/FCF Ratio	n/a
P/OCF Ratio	6.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.27, with an EV/FCF ratio of -86.05.

EV / Earnings	57.88
EV / Sales	4.80
EV / EBITDA	18.27
EV / EBIT	57.92
EV / FCF	-86.05

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.18.

Current Ratio	1.10
Quick Ratio	0.31
Debt / Equity	0.18
Debt / EBITDA	2.32
Debt / FCF	-12.27
Interest Coverage	38.09

Financial Efficiency

Return on equity (ROE) is 2.14% and return on invested capital (ROIC) is 1.55%.

Return on Equity (ROE)	2.14%
Return on Assets (ROA)	1.42%
Return on Invested Capital (ROIC)	1.55%
Return on Capital Employed (ROCE)	2.71%
Revenue Per Employee	5.82M
Profits Per Employee	482,619
Employee Count	239
Asset Turnover	0.20
Inventory Turnover	1.60

Taxes

Income Tax	-3.12M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.41% in the last 52 weeks. The beta is -0.10, so SCI Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-46.41%
50-Day Moving Average	51.03
200-Day Moving Average	61.85
Relative Strength Index (RSI)	43.27
Average Volume (20 Days)	105,865

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCI Pharmtech had revenue of TWD 1.39 billion and earned 115.35 million in profits. Earnings per share was 0.96.

Revenue	1.39B
Gross Profit	346.27M
Operating Income	159.70M
Pretax Income	112.23M
Net Income	115.35M
EBITDA	405.80M
EBIT	159.70M
Earnings Per Share (EPS)	0.96

Balance Sheet

The company has 77.69 million in cash and 952.08 million in debt, giving a net cash position of -874.39 million or -7.32 per share.

Cash & Cash Equivalents	77.69M
Total Debt	952.08M
Net Cash	-874.39M
Net Cash Per Share	-7.32
Equity (Book Value)	5.37B
Book Value Per Share	44.94
Working Capital	96.94M

Cash Flow

In the last 12 months, operating cash flow was 949.78 million and capital expenditures -1.03 billion, giving a free cash flow of -77.59 million.

Operating Cash Flow	949.78M
Capital Expenditures	-1.03B
Free Cash Flow	-77.59M
FCF Per Share	-0.65

Margins

Gross margin is 24.91%, with operating and profit margins of 11.49% and 8.30%.

Gross Margin	24.91%
Operating Margin	11.49%
Pretax Margin	8.07%
Profit Margin	8.30%
EBITDA Margin	29.19%
EBIT Margin	11.49%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 3.08%.

Dividend Per Share	1.50
Dividend Yield	3.08%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	155.41%
Buyback Yield	-0.89%
Shareholder Yield	2.19%
Earnings Yield	1.99%
FCF Yield	-1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	1.125

Scores

SCI Pharmtech has an Altman Z-Score of 4.39 and a Piotroski F-Score of 5.

Altman Z-Score	4.39
Piotroski F-Score	5